Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy

Overview of attention for article published in PharmacoEconomics, August 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

facebook: 1 Facebook page

Readers on

mendeley: 79 Mendeley

Summary X Facebook

So far, Altmetric has seen 1 public wall post.

Healtheconbot, 09 Aug 2017

#HealthEconJA Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario…